Health Care · Surgical & Medical Instruments & Apparatus · Nasdaq · CIK 1116463 · FYE Dec 31 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
Last $3.97Day +0.00%Mkt cap $273M1Y +24.5%Off 52W high −13.3%Vol (1Y) 48.2%
Daily closing price, split-adjusted to the current basis; 3y shown of 5,294 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest4.7% of sh out |
| Days to cover9.0d |
| 13F net flow (QoQ)−2.05% |
| Top-10 13F concentration60.6% |
| Next report (est.)2026-08-06 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$113.0M |
| Earnings (TTM)-$75.1M |
| ROE−18.3% |
| Net margin−59.8% |
| ROIC−40.0% |
| Sales growth 3Y−33.3% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+64.0% |
| 1Y+24.5% |
| 3Y−15.9% |
| 5Y−66.3% |
| 10Y−41.7% |
| Since incept. (ann.)−4.8% |
Total return through 2026-07-30 · series begins 2005-07-11. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)48.2% |
| Ann. volatility (3Y)51.4% |
| Sharpe (1Y)0.65 |
| Sharpe (3Y)0.14 |
| Max drawdown (1Y)−39.4% |
| Max drawdown (3Y)−74.7% |
| Beta (3Y vs SPY)1.21 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| BlackRock, Inc. | 6.5M | $20M | 9.43% | +1.1% |
| PRIVATE MANAGEMENT GROUP INC | 5.4M | $16M | 7.84% | +0.5% |
| NEUBERGER BERMAN GROUP LLC | 4.4M | $13M | 6.31% | +9.5% |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.0M | $9M | 4.38% | new |
| DIMENSIONAL FUND ADVISORS LP | 2.8M | $8M | 4.08% | −13.4% |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 2.5M | $7M | 3.59% | +0.1% |
| RENAISSANCE TECHNOLOGIES LLC | 2.1M | $6M | 3.01% | −2.9% |
| ACADIAN ASSET MANAGEMENT LLC | 2.0M | $6M | 2.93% | +0.0% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-06 | −$0.32 | — | $27.9M | −6.7% |
| 2025-12-31 | 2026-02-25 | — | — | $26.8M | −28.5% |
| 2025-09-30 | 2025-11-05 | −$0.19 | — | $27.1M | −32.1% |
| 2025-06-30 | 2025-08-05 | −$0.26 | — | $31.2M | −42.5% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-06 is ESTIMATED from filing cadence (median gap 92d) — not company-confirmed.
US 68% · Africa 21% · Europe 6% · Other Foreign Countries 5%
geographic · each slice's share of TAGGED segment revenue in the latest annual filing (XBRL, as filed). Untagged revenue is excluded from the denominator, so slices need not sum to consolidated sales.
